Atlas Trials

A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

Clinical trial NCT00644800 · COMPLETED

Trial details

NCT number
NCT00644800
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaManiaDelusional DisorderAcute Exacerbation of Psychosis
Start date
2003-07-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.